VeolityTM brings FDA approved CAD of lung nodules, registration of prior studies and automated measuring of nodules into clinical routine. 3. Fully integrated solid pulmonary nodule CAD Veolity marks regions that are suggestive of solid pulmonary nodules automatically. This helps radiologists to quickly identify regions that demand further analysis. TM 4. Automatic segmentation A simple double click on a suspicious region automatically segments the nodule – even for sub-solid lesions. Contact MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone +49 421 - 22495 0 Fax +49 421 - 22495 999 E-mail: [email protected] www.mevis.de www.veolity.com 5. Advanced nodule reporting The report automatically summarizes ndings of current and prior studies and is sent to PACS on "study sign o". Standardized Lung-RADSTM reporting will be available in the upcoming version. 6. Client-server technology Physicians can concentrate on reading the cases. They just start the client software on their workstation. All processing (CAD, registration etc.) has already been accomplished on the server, and cases are assigned to all clients allowing to spread the workload. veo l i ty Lung Screening. Improve your reading workow and diagnostic quality

The workstation for your lung screening program. Lung cancer screening Lung cancer is the most common cancer worldwide and causes the most cancer deaths each year. 1.8 million new cases (13% of all cancer cases) occurred in 2012 worldwide with a mortality of 1.6 million (19% of all cancer deaths).1 As small lung tumors are typically not causing pain or other discomfort, many patients present only when their condition is symptomatic, which means treatment has become dicult. It is essential to catch the disease at an early stage, when treatment is most eective. Veolity TM enables efficient, highthroughput...